Venus Medtech (启明医疗) Pre-IPO: Thoughts on Valuation
Venus Medtech (Hangzhou) is a dominant player in the heart valve replacement devices market in China. The company started pre-marketing for a USD...
518 Views
Shanghai Kindly (康德莱医疗) IPO - Cardiovascular Device Leader Backed by Strong Cornerstone
Shanghai Kindly Medical Instrument is a leading domestic player in the cardiovascular interventional device market, particularly the Percutaneous...
476 Views
Venus Medtech (启明医疗) IPO: Technical Comparison of VenusA-Valve and Peers
Venus Medtech, a China Hangzhou-based transcatheter heart valve medical device player, is looking to raise up to USD 300 million via a listing in...
675 Views
Venus Medtech (启明医疗) IPO: Has the Elements for a Hot Healthcare Deal
Venus Medtech, a China Hangzhou-based transcatheter heart valve medical device player, is looking to raise up to USD 300 million via a listing in...
840 Views
Last Week in GER Research: WeWork, Venus Medtech, Fineos, Takara Leben, TPV Tech, and Douya/Huya
Below is a recap of the key IPO and event-driven research produced by the Global Equity Research team. This week, we dig into the stretched balance...
419 Views